Susman shared Tuesday that she’ll be stepping down from her role as EVP and chief corporate affairs officer after 18 years with the company. Susman joined Pfizer in 2007 and helped lead the company ...

One of the best known communications executives in corporate America, Susman worked at Pfizer for nearly two decades after ...

Pfizer (PFE) stock in focus as Sally Susman, the company's Chief Corporate Affairs Officer, plans to depart after 18 years.

Pfizer chief corporate affairs officer Sally Susman is departing the company after roughly two decades, CEO Albert Bourla ...

Pfizer recently announced positive results from the BASIS study, the global phase 3 trial evaluating Hympavzi in young adults ...

BRUSSELS (CNS) — European Commission President Ursula von der Leyen defended herself before the European Parliament Monday as ...

The Justice Department changed its policy on foreign corruption cases, which might have put an end to investigations into the ...

The House Judiciary Committee subpoenaed a former Pfizer executive who allegedly claimed senior members of the company ...

Proponents say direct-to-consumer sales by drugmakers cut out intermediaries that add needlessly to prices. Detractors see ethical issues and prices that are still too high for many patients.

The strategies that the industry’s lobbyists use, or don’t deploy, matter as the Trump administration moves more decisively ...

The House Judiciary Committee has subpoenaed a former Pfizer executive who is considered central to its investigation into an ...

House Judiciary Chair Jim Jordan subpoenaed Dr. Philip Dormitzer after he refused to testify in the 2020 vaccine delay probe, ...